Cognitive Improvement Through tDCS for Patients With Multiple Sclerosis
Sponsored by University Medicine Greifswald
About this trial
Last updated 2 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Ended 2 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- diagnosis of multiple sclerosis.
- no acute inflammation during the last 3 months before the experimental intervention.
- no cortisol treatment during the last 3 months before the experimental intervention.
- stable medication during the experimental intervention.
- unrestrained or corrected visual ability.
- ability to read and write short german sentences.
- adequate motor ability to give responses on a keyboard.
- German as main language.
Exclusion Criteria
- major depressive symptoms or any further neurological and/or psychiatric disease at experimental intervention.
- standard tDCS exclusion criteria (e.g. cardiac pacemaker, metal implants in head region, etc.)